
The British healthcare system, the National Health Service (NHS), has come up with a subscription scheme giving patients with serious infections access to antimicrobial drugs, according to a news release.
NHS patients who are at risk of developing drug resistance due to life-threatening infections, such as sepsis, ventilator pneumonia, and blood stream infections, can now be offered one of two antibiotics: Shionogi’s cefiderocol or Pfizer’s ceftazidime-avibactam.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app